Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Eke

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Biology|December 7, 2007
Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitroIris Eke, Veit Sandfort, Katja Storch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2009
Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cellsStephanie Hehlgans, Iris Eke, Katja Storch, et al.
Seminars in Radiation Oncology|September 14, 2016
Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted TherapyAdeola Y Makinde, Iris Eke, Molykutty J Aryankalayil, et al.
Cancer Research|October 18, 2012
EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cellsIris Eke, Lydia Schneider, Claudia Förster, et al.
Cancer Letters|February 2, 2016
Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicineIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 29, 2008
Expression of integrin-linked kinase is increased in differentiated cellsMichael Haase, Christine C Gmach, Iris Eke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2015
EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasionMandy Poschau, Ellen Dickreuter, Jenny Singh-Müller, et al.
Cancer Research|May 6, 2010
Three-dimensional cell growth confers radioresistance by chromatin density modificationKatja Storch, Iris Eke, Kerstin Borgmann, et al.
Journal of the National Cancer Institute|February 10, 2015
Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancerIris Eke, Katja Zscheppang, Ellen Dickreuter, et al.
The Journal of Clinical Investigation|March 2, 2012
β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyIris Eke, Yvonne Deuse, Stephanie Hehlgans, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Biology|December 7, 2007
Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitroIris Eke, Veit Sandfort, Katja Storch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2009
Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cellsStephanie Hehlgans, Iris Eke, Katja Storch, et al.
Seminars in Radiation Oncology|September 14, 2016
Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted TherapyAdeola Y Makinde, Iris Eke, Molykutty J Aryankalayil, et al.
Cancer Research|October 18, 2012
EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cellsIris Eke, Lydia Schneider, Claudia Förster, et al.
Cancer Letters|February 2, 2016
Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicineIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 29, 2008
Expression of integrin-linked kinase is increased in differentiated cellsMichael Haase, Christine C Gmach, Iris Eke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2015
EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasionMandy Poschau, Ellen Dickreuter, Jenny Singh-Müller, et al.
Cancer Research|May 6, 2010
Three-dimensional cell growth confers radioresistance by chromatin density modificationKatja Storch, Iris Eke, Kerstin Borgmann, et al.
Journal of the National Cancer Institute|February 10, 2015
Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancerIris Eke, Katja Zscheppang, Ellen Dickreuter, et al.
The Journal of Clinical Investigation|March 2, 2012
β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyIris Eke, Yvonne Deuse, Stephanie Hehlgans, et al.
Pageof 5